III DRIEX
LIVE

Serial Number

79371355

Owner

BORMIOLI PHARMA S.p.A.

Attorney

Zachary A. Aria

Filing Date

Apr 19, 2022

Add to watchlist:

No watchlists yet
View on USPTO

III DRIEX Trademark

Serial Number: 79371355 • Registration: 7646352

III DRIEX is a trademark filed by BORMIOLI PHARMA S.p.A. on April 19, 2022. The trademark is classified under Class 10 (Medical Apparatus), Class 20 (Furniture), Class 21 (Housewares). The application is currently registered and active.

Owner Contact Info

BORMIOLI PHARMA S.p.A. (16 trademarks)

Corso Magenta 84

Entity Type: 99

Trademark Details

Filing Date

April 19, 2022

Registration Date

January 14, 2025

Published for Opposition

September 17, 2024

Goods & Services

Flasks for parenteral nutrition namely, container and drug reconstitution system for injections, infusions and orals, all being medical apparatus in the nature of infusion and injection devices for administering drugs; dropper bottles for medical purposes, in particular for bottles for administering medication, sold empty; vaporizers for medical purposes; suction bottles for medical use, namely feeding bottles, nursing bottles, and dropper bottles for administering medication, sold empty; dropper bottles for administering medication, sold empty; syringes for medical purposes; syringes for injections; haemoperfusion cartridges being structural part of dialysis machines and blood containers for medical purposes; feeding bottles; droppers for medical purposes in particular for administering medication, sold empty; droppers for administering medication, sold empty; trays for holding surgical instruments; measuring spoons for administering medicine; spoons for administering medicine; non-spill medicine administering spoons for infants; intravenous feeding bottles; breast milk storage bottles; medical tubing for administering drugs; injection device for pharmaceuticals; dropping pipettes for medical purposes; diagnostic devices namely, sample preparation device for medical diagnostic use, blood pressure and diabetic diagnostic medical devices, and diagnostic kit consisting primarily of probes, buffers and reagents for use in microbial testing used in laboratories for Point of Care Testing (POCT) for integrated electronic systems for the administration of medical substances; consumable laboratory cartridges for diagnostic purposes, namely, replacement and structural components of medical diagnostic apparatus for detecting diseases, integrated electronic system for the administration of medical substances being drug delivery systems and medical instruments for measuring and displaying blood pressure and lung capacity; medical devices, namely valves and accessories being tubing for intravenous drug administration; apparatus sold as a unit in kit form for medical diagnostic purposes, namely diagnostic kits for clinical medical use primarily containing sample preparation devices for medical diagnostics and also containing test tubes, test plates and indicator charts for evaluating test results; test kits for clinical medical use consisting primarily of sample preparation devices for medical diagnostics and also containing a holder for medical sample tubes and vials also including test tubes, test plates and indicator charts for evaluating test results; containers for medical reagents, namely, containers specially designed for transporting and holding radiopharmaceuticals; systems comprising medical apparatus and accessories for administering measured doses of medical substances, namely medical apparatus and accessories being dosage dispensers for administering medicine to patients, infusion and injections devices for administering drugs; medical instruments for recording physiological data for medical and pharmaceutical purposes in particular for measuring blood pressure; medical prostheses being bone, hip and breast prostheses and implants for surgical purposes comprising artificial materials; sterile containers to be filled with medical products, namely, containers for medical waste, blood containers for medical purposes sold empty; sterile containers for surgical purposes namely, containers for medical waste, blood containers for medical purposes sold empty; empty medical diagnostic cartridges of plastic for containing and administering medical products, namely blood cartridge containers for medical use sold empty; empty medical diagnostic cartridges of glass for containing and administering medical products, namely blood cartridge containers for medical use sold empty; empty medical diagnostic cartridges of plastic for containing and administering reagents namely capillary reagent tubes for medical use; empty medical diagnostic cartridges of glass for containing and administering reagents, namely capillary reagent tubes for medical use; medical needles of metal for parenteral administration; auxiliary medical devices for drug reconstitution, namely tubing for intravenous drug administration; cartridges of plastic for medical diagnostic purposes, namely blood cartridge contains for medical use sold empty; containers made of glass or plastic for pharmaceutical or parapharmaceutical or medical use, namely dropper bottles for administering injectable medication substances sold empty, medical syringes and empty medical diagnostic cartridges being blood cartridge contains for medical use sold empty

Cruets; cruet stands; contains for household use, namely glass bulbs; flasks; flasks of plastic; empty spray bottles; glass cartridges for medication, empty; pill boxes for personal use; personal dispensers for pills or capsules for domestic use, namely pill boxes for personal use; droppers for cosmetic purposes; glasses, namely drinking glasses; bottles sold empty; containers being glass flasks; plastic bottles sold empty; drip preventers for bottles in the nature of bottle pourers; glass stoppers for bottles; bottles for pharmaceuticals sold empty; apothecary jars, namely glass jars; dispensers for liquids for use with bottles, namely pouring spouts for household use all for use with bottles; containers made of glass or plastic for pharmaceutical or parapharmaceutical or medical use, namely bottles for medicines, bottles for reagents, bottles for infusions, bottles for aerosols, glass vials for medication, glass ampoules for medication, pill bottles, all sold empty; medicinal bottle stoppers of glass

Container closures of plastic; plastic medication containers for commercial use; containers, not of metal for commercial use; bottle closures, not of metal; closures for containers, non-metallic; corks for bottles; plastic stoppers for bottles; plastic screw caps and caps of plastic for the closure of containers; sealing caps, not of metal; closures of plastics for containers for detecting tampering

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 8, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 23, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 23, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 14, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 14, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 14, 2025 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 23, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 6, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 6, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 14, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 19, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 4, 2024 GNFN
FINAL REFUSAL E-MAILED
Mar 4, 2024 GNFR
FINAL REFUSAL WRITTEN
Mar 4, 2024 CNFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 31, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 31, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 31, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 31, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 31, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 31, 2024 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2024 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 4, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 3, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 13, 2023 RFCR
APPLICATION FILING RECEIPT MAILED
Jun 13, 2023 MAFR
NON-FINAL ACTION WRITTEN
Jun 12, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 9, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 8, 2023 REPR